The predictive and prognostic values of ANGPTL2 in CRC are also supported in a recent study where authors showed that higher expression of ANGPTL2 in primary tumor tissues is related to aggressive phenotype of tumor cells and enhances resistance to antineoplastic drugs through apoptosis antagonism. The gene discussed is ANGPTL2; the disease is colorectal carcinoma.